-
Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
July 23, 2026 21:08 ET | Source: Scribe Therapeutics Inc. ALAMEDA, Calif., July 23, 2026 (GLOBE NEWSWIRE) — Scribe Therapeutics Inc. (“Scribe Therapeutics”) (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and durable therapeutic intervention, today announced the pricing of its upsized initial…
-
Quantinuum Announces Closing of Upsized Initial Public Offering
BROOMFIELD, Colo., June 5, 2026 /PRNewswire/ — Quantinuum Inc. (Nasdaq: QNT) (“Quantinuum”) today announced the closing of its upsized initial public offering of 28,000,000 shares of its Class A common stock at an initial public offering price of $60.00 per share. All of the shares were offered by Quantinuum. The aggregate gross proceeds from the…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.